Ep 4: MedTech in Southeast Asia’s Advancing Capabilities

In our fourth episode, Alfred Lum, Chief Commercial Officer of InCorp, with James Lim, Executive VP and President of Greater Asia at Becton Dickinson (BD), and Kenny Ng, Regional Director (Americas) of Singapore Economic Development Board (EDB), discussed why Singapore and Southeast Asia healthcare make prime targets for MedTech companies to expand their operations.

For more information and inquiries, do contact us at:
InCorp Global Singapore Office Address:
36 Robinson Road, #20-01,
City House, Singapore 068877.

Connect with our experts at:
Web: http://www.incorp.asia
Email: hello@incorp.asia
Office Phone: +65 6990 8220
WhatsApp: +65 8699-8821

Read more about Fund Structuring & Administration Services here:
https://www.incorp.asia/singapore/services/fund-structuring-and-administration

Chapters

• 1:11 Introduction of: Kenny Ng, Regional Director, Americas from Singapore EDB
• 1:41 Introduction of: James Lim, Executive VP and President, Greater Asia of Becton Dickinson (BD)
• 3:08 Overview of the growing MedTech landscape in Southeast Asia
• 3:47 Key drivers for MedTech in the Southeast Asia region
• 5:43 Trends and Business opportunities in Southeast Asia pertaining to MedTech
• 9:20 Innovation for MedTech in Southeast Asia
• 11:20 How do regulations affect the emergence of MedTech firms?
• 13:45 Main benefits of choosing Singapore as the location for headquarters
• 16:45 Considerations for setting up a MedTech company in Singapore
• 21:05 Why Southeast Asia is a winning proposition for BD MedTech